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Introduction: Obesity (OB) is associated with chronic mild inflamma-
tion and higher gestational risks. OB is also associated with oxidative
stress. Periodontal diseases (PD), i.e gingivitis (G) and periodontitis (P)
may also represent a source of low-grade systemic inflammation
potentially impairing pregnancy outcomes. We previously showed
increased oral inflammation in obese (OB) compared to normal
weight (NW) pregnant women. Few studies investigated saliva (S)
biomarkers in pregnant women. Here we analyzed C-reactive protein
(CRP) concentrations and total antioxidant capacity (TAC) in saliva of
pregnant women with different pre-pregnancy BMI, investigating
their association with plasma CRP and with PD.
Materials and methods: 59 singleton pregnancies (15 NW, BMI 18-24.9;
44 OB, BMI 30) were studied at 3rd trimester. 15 obese women had
gestational diabetes mellitus (GDM). Periodontal status was assessed
by oral clinical examination in 24 OB and 15 NW. P: at least 4 teeth
with pockets 4mm. G: soft and/or calcified bacterial plaque and/or
gingival bleeding in 4 or more teeth. In 36 women (15NW, 21OB - 8
with/13 no GDM) unstimulated S-samples were collected for analysis
of CRP (ELISA) and TAC (AntiOxidant Assay). CRP was also measured in
44 (10NW, 34OB -11 with/23 no GDM) plasma samples (ELISA). Clinical
and molecular data were compared between groups using indepen-
dent-sample t-test adjusted by Levene’s test. Correlations between
values were assessed by Pearson test. Results were considered
significant when p50.05.
Clinical cases and summary results: S-CRP levels were significantly
related to BMI (p=0.03; R=0.44), with increased content in OB vs NW,
reaching significance in OB with GDM (p=0.04). TAC was significantly
higher in all OB vs NW (total OB vs NW: p=0.01; OB without GDM vs
NW: p=0.04; OB with GDM vs NW: p=0.01) and significantly correlated
with S-CRP (p=0.00; R=0.77). Plasma CRP levels were significantly
increased in all OB vs NW (total OB vs NW: p=0.00; OB without GDM vs
NW: p=0.05; OB with GDM vs NW: p=0.01), correlating with both
S-CRP (p=0.00; R=0.65) and TAC (p=0.00; R=0.59). 83.3% OB and 40%
NW had PD (P/G). PD in NW did not enhance molecular values, while
in OB the presence of PD increased CRP/TAC compared to healthy
NW, reaching significance for both S-TAC (p=0.02) and plasma CRP
(p=0.018).
Conclusion: Mild inflammation was reported in many OB tissues, but
nothing is known on markers in S of OB pregnant women, which
represents an effective non-invasive diagnostic tool. CRP increase in
OB plasma, marker of systemic inflammation, was confirmed in S.
Higher S-TAC suggests the induction of a systemic antioxidant
response detectable in OB-S. GDM possibly contributes to these
increases. The higher PD frequency in OBvsNW might enhance CRP
and compensatory antioxidant defenses in women with both OB-PD
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Introduction: Objective to determinate body mass index (BMI) and
hemoglobin A1c (HbA1c) levels, as predictors of insulin therapy (IT),
on fetal echography findings and perinatal outcomes in pregnancies
were complicated by diabetes mellitus (DM).
Materials and methods: Material and Methods we intended to
evaluate the values of BMI and HbA1c levels on fetal interventricular
septum (IVS) thickness, atrioventricular inflow E/A velocity ratio and
perinatal outcomes. According to IT, we evaluated three groups of 32
patients of gestational DM treated with dietary changes, (GDMA1
group), 27 patients of GDM with IT (GDMA2 group) and 22 patients of
type 1 diabetes (T1D group) in the 38th gw.
Clinical cases and summary results: Results In T1D group, we found
statistical significant correlation BMI to IVS thickness (p 0.036); HbA1c
to IVS thickness as well as mitral E/A velocity ratio (p 0.013 vs. p
0.007). In T1D group, HbA1c showed statistically significant correla-
tion to BW (p 0.037). We determinated statistically significant
difference between BMI and neonatal RDS (p 0.027). Statistically
significant difference was confirmed between HbA1c level and RDS,
as well as ICH in T1DM group (p 0.048 vs. p 0.018). HbA1c was
statistically different to RDS in GDMA2 group (p 0.036).
Conclusion: Conclusion in DM and GDM pregnancies, maintaining
optimal glucose levels determine fetal echography findings and
perinatal outcomes.
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Introduction: The Finnish Current Care Guideline recommends fasting
plasma glucose (PG) 5.3, 1h PG 10.0, or 2h PG 8.6mmol/l in a
75g oral glucose tolerance test (OGTT) as thresholds for gestational
diabetes (GDM) diagnosis in both early (12-16 weeks) and late (24-28
weeks) gestation. Based on the HAPO study, the International
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